The US-based Acorda Therapeutics, Inc has entered into a settlement agreement with Aurobindo Pharma to resolve pending patent litigation brought by the company against Aurobindo involving Ampyra (dalfampridine) Extended-Release Tablets
| Subscribe To Our Free Newsletter |
